While reporting financial results for the fourth quarter on Wednesday, biopharmaceutical company Ligand Pharmaceuticals Inc. (LGND) raised its adjusted earnings and revenue guidance for the full-year 2021.
from RTT - Earnings https://ift.tt/3rgQCZL
via IFTTT
No comments:
Post a Comment